Fifth Third Wealth Advisors LLC Halozyme Therapeutics, Inc. Transaction History
Fifth Third Wealth Advisors LLC
- $2.71 Trillion
- Q3 2025
A detailed history of Fifth Third Wealth Advisors LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Fifth Third Wealth Advisors LLC holds 4,259 shares of HALO stock, worth $283,095. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,259
Previous 4,294
0.82%
Holding current value
$283,095
Previous $223 Million
39.83%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding HALO
# of Institutions
623Shares Held
127MCall Options Held
408KPut Options Held
388K-
Black Rock Inc. New York, NY17.6MShares$1.17 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$814 Million0.01% of portfolio
-
State Street Corp Boston, MA5.94MShares$395 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.47MShares$230 Million0.03% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.4MShares$226 Million3.92% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $9.26B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...